Center for Tropical and Emerging Global Diseases, University of Georgia, Athens, GA 30602, USA.
J Immunol. 2010 Jul 1;185(1):560-8. doi: 10.4049/jimmunol.1000432. Epub 2010 Jun 7.
CD8(+) T cells are essential for controlling Trypanosoma cruzi infection. During Brazil strain infection, C57BL/6 mice expand parasite-specific CD8(+) T cells recognizing the dominant TSKB20 (ANYKFTLV) and subdominant TSKB74 (VNYDFTLV) trans-sialidase gene (TS)-encoded epitopes with up to 40% of all CD8(+) T cells specific for these epitopes. Although this is one of the largest immunodominant T cell responses described for any infection, most mice fail to clear T. cruzi and subsequently develop chronic disease. To determine if immunodominant TS-specific CD8(+) T cells are necessary for resistance to infection, we epitope-tolerized mice by high-dose i.v. injections of TSKB20 or TSKB74 peptides. Tolerance induction led to deletion of TS-specific CD8(+) T cells but did not prevent the expansion of other effector CD8(+) T cell populations. Mice tolerized against either TSKB20 or TSKB74, or both epitopes simultaneously, exhibited transient increases in parasite loads, although ultimately they controlled the acute infection. Furthermore, BALB/c mice tolerized against the TSKD14 peptide effectively controlled acute T. cruzi infection. These data are consistent with the hypothesis that development of high-frequency CD8(+) T cell populations focused on TS-derived epitopes contributes to optimal control of acute infection but is not required for the development of immune resistance.
CD8(+) T 细胞对于控制克氏锥虫感染至关重要。在巴西株感染期间,C57BL/6 小鼠扩增了寄生虫特异性 CD8(+) T 细胞,这些细胞识别主要的 TSKB20(ANYKFTLV)和亚优势的 TSKB74(VNYDFTLV)转涎酶基因(TS)编码表位,其中多达 40%的 CD8(+) T 细胞特异性针对这些表位。尽管这是描述的任何感染中最大的免疫显性 T 细胞反应之一,但大多数小鼠无法清除克氏锥虫,随后发展为慢性疾病。为了确定免疫显性 TS 特异性 CD8(+) T 细胞是否是抵抗感染所必需的,我们通过静脉内高剂量注射 TSKB20 或 TSKB74 肽使小鼠产生免疫显性 TS 特异性 CD8(+) T 细胞耐受。耐受诱导导致 TS 特异性 CD8(+) T 细胞的删除,但不能防止其他效应 CD8(+) T 细胞群的扩增。针对 TSKB20 或 TSKB74 或同时针对两个表位耐受的小鼠,尽管最终它们控制了急性感染,但寄生虫负荷会短暂增加。此外,BALB/c 小鼠针对 TSKD14 肽的耐受有效地控制了急性克氏锥虫感染。这些数据与以下假设一致,即针对 TS 衍生表位的高频 CD8(+) T 细胞群体的发展有助于对急性感染的最佳控制,但对于免疫抗性的发展并非必需。